SEX DIFFERENCE IN HEALTH AND SURVIVAL IN STREPSIRRHINE PRIMATES
链球菌灵长类动物健康和生存的性别差异
基本信息
- 批准号:8314014
- 负责人:
- 金额:$ 10.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAffectAgeAgingAging-Related ProcessAnimal ModelAnimalsAntioxidantsBehaviorBehavioralBiodiversityBiologicalBreedingCause of DeathCharacteristicsCheirogaleusCross-Sectional StudiesDataDatabasesDemographyDisadvantagedEcologyElementsEnvironmentEstradiolFaceFemaleFranceFree RadicalsGenderGerman populationGonadal Steroid HormonesGray unit of radiation doseHealthHealth StatusHousingHumanHuman CharacteristicsHydrocortisoneImmune systemImmunocompetenceIndividualInstructionInvestmentsLaboratory StudyLemursLifeLightLongitudinal StudiesMadagascarMeasuresMedical HistoryModelingMonitorMouse LemurOutputOxidative StressOxygenParasitesPathologyPatternPhysical FunctionPhysiologicalPhysiologyPopulationPrimatesProductionProteinsResearchResourcesRetrospective StudiesRiskSeasonsSex CharacteristicsStatistical ModelsSteroidsTestingTestosteroneTimeWomen&aposs Healthbasecombatcomparativecosthuman maleinterestmalemale healthmortalitynonhuman primateoxidative damagepathogenreproductivesex
项目摘要
Project 6: Sex Differences in Health and Suvival in Strepsirrhine Primates
This project will elucidate potential mechanisms underlying the paradox that human males face a survival
disadvantage throughout life, despite a seemingly better state of health, especially at old ages. Taking
advantage of some of the unique characteristics of Strepsirrhine primates, severalevolution-based
hypotheses will be evaluated. The first researchaim is to quantifythe survival consequences of 'risky male
behaviors' by dissecting annual survival into time periods when the behaviors of interest occur. Sex-specific
survival estimates for wild populations of Microcebus murinus and Cheirogaleus medius will be obtained by
statistical modeling of capture-mark-recapture data. In aim 2, the hypothesis will be tested that whereas
males outperform females in (physical) functioning, females retain higher immunocompetence. To evaluate
this idea, sex-specificage trajectories of functioning and immunocompetence will be constructed for several
elements of these two health components using animals from a large captive colony of M. murinus.
Additionally, sex differences in health status and causes of death will be analyzed for severalStrepsirrhine
species in a retrospective study using the medical histories database of the Duke Lemur Center. In the third
aim we will assess the sex differences in seasonal patterns of health over age by comparing indicators of
health during the reproductive (high steroid levels) and non-reproductive (low steroid levels) season. To this
end, sex-/season-specific immunocompetence and concomitant steroid levels will be measured in captive M.
murinus, and sex-/season-specific parasite loads in two wild populations will be quantified. In aim 4 we will
test the hypothesis that (due to a more active immune system)females have higher levels of free radical
production, but also higher antioxidant defenses comparedto males. In a longitudinal study we will monitor
levels of.oxidative stress (reactive oxygen metabolites and antioxidant levels) and oxidative protein damage
during aging in both sexes of M. murinus.
RELEVANCE (See instructions):
The proposed research will advance the development of Strepsirrhine primates, especially the gray mouse
lemur (M. murinus) as a non-human primate model of aging, and also extend its domain to address
questions on gender-specific health and aging. Ultimately, understanding some of the proximatefactors
behind sex differences in survival and health will help to addressgender-specific health issues more
efficiently and to predict sex-differentials in survival and health in a given context.
项目6:链球菌属灵长类动物健康和生存的性别差异
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE YODER其他文献
ANNE YODER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE YODER', 18)}}的其他基金
SEX DIFFERENCE IN HEALTH AND SURVIVAL IN STREPSIRRHINE PRIMATES
链球菌灵长类动物健康和生存的性别差异
- 批准号:
8379395 - 财政年份:
- 资助金额:
$ 10.48万 - 项目类别:
SEX DIFFERENCE IN HEALTH AND SURVIVAL IN STREPSIRRHINE PRIMATES
链球菌灵长类动物健康和生存的性别差异
- 批准号:
7668930 - 财政年份:
- 资助金额:
$ 10.48万 - 项目类别:
SEX DIFFERENCE IN HEALTH AND SURVIVAL IN STREPSIRRHINE PRIMATES
链球菌灵长类动物健康和生存的性别差异
- 批准号:
8531102 - 财政年份:
- 资助金额:
$ 10.48万 - 项目类别:
SEX DIFFERENCE IN HEALTH AND SURVIVAL IN STREPSIRRHINE PRIMATES
链球菌灵长类动物健康和生存的性别差异
- 批准号:
8136156 - 财政年份:
- 资助金额:
$ 10.48万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 10.48万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 10.48万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 10.48万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 10.48万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 10.48万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 10.48万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 10.48万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 10.48万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 10.48万 - 项目类别: